Novartis AG

Lezárt

155.3 0.28

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

154.7

Maximum

156.28

Fő mutatók

By Trading Economics

Bevétel

747M

3.2B

Értékesítés

189M

14B

P/E

Szektor átlag

21.337

50.958

Egy részvényre jutó nyereség

1.65

Osztalékhozam

3.18

Profit margin

23.336

Munkavállalók

75,267

EBITDA

338M

5.4B

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+10.07% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

3.18%

2.41%

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

5.9B

284B

Előző nyitás

155.02

Előző zárás

155.3

Novartis AG Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. jún. 26. 23:56 UTC

ETF Constituents

The Consumer Discretionary Select Sector SPDR Fund gained after-market hours, led by Amazon's 0.72% return, amid broader market weakness from inflation concerns.

2026. jún. 26. 23:56 UTC

eBay Inc shares are higher in after-market trading, reaching the upper end of their one-month trading range. No specific news was identified for this movement.

2026. jún. 26. 23:56 UTC

Paychex Inc shares declined in after-market trading, retracing from earlier gains. No specific company news was identified to explain the price movement.

2026. jún. 26. 23:52 UTC

Mexican Consumer Confidence Index Set for Release Amid Low Sentiment and Economic Concerns on July 3, 2026.

2026. jún. 26. 23:51 UTC

Event

Incyte Corp shares are higher in after-market trading following a positive recommendation for Opzelura® cream from the European Medicines Agency's Committee for Medicinal Products.

2026. jún. 26. 23:51 UTC

Correlated Moves

After-market trading for the Dow Jones Index is lower, reflecting risk-off sentiment amid inflation concerns following significant price increases announced by Apple.

2026. jún. 26. 23:51 UTC

Correlated Moves

The Russell 2000 Index is lower in after-market trading, reflecting broader market sentiment influenced by declines in correlated indices and inflationary concerns.

2026. jún. 26. 23:51 UTC

Correlated Moves

The S&P 500 Index is trading lower in after-market hours, continuing a decline since Friday. Broader market sentiment reflects weakness in correlated assets.

2026. jún. 26. 23:51 UTC

Macro News
ETF Constituents

The Financial Select Sector SPDR Fund rose in after-market hours as the U.S. Dollar declined, easing interest rate hike concerns. Key holdings also performed well.

2026. jún. 26. 23:51 UTC

Global equity markets decline amid inflation concerns, with Asia's Nikkei 225 down 4.5% and U.S. mixed as consumer sentiment improves but trade deficit surges.

2026. jún. 26. 23:51 UTC

U.S. equity markets show mixed performance amid global declines and inflation concerns, with key economic data on labor market conditions set for release next week.

2026. jún. 26. 23:51 UTC

Asia and European equity markets decline amid tech sector concerns, while U.S. indices show mixed results despite strong earnings from Eli Lilly and Microsoft.

2026. jún. 26. 23:51 UTC

European equity indices decline amid rising inflation concerns and worsening labor market conditions, with Germany's DAX down 1.3% and Japan's Nikkei 225 down 4.5%.

2026. jún. 26. 23:51 UTC

News

iShares 20+ Year Treasury Bond ETF declines in after-market trading amid heightened geopolitical tensions from military actions in the Middle East.

2026. jún. 26. 23:51 UTC

Correlated Moves

The VanEck J. P. Morgan EM Local Currency Bond ETF is near unchanged in after-market trading amid lower global equity indices and ongoing inflation concerns.

2026. jún. 26. 23:51 UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average.

2026. jún. 26. 23:51 UTC

PayPal Holdings Inc. shares are lower in after-market hours, reflecting broader market risk-off sentiment amid inflation concerns following price increases announced by Apple.

2026. jún. 26. 23:51 UTC

NXP Semiconductors NV is higher in after-market hours, tracking overall market gains. No specific company news was identified to explain the movement.

2026. jún. 26. 23:51 UTC

T-Mobile US Inc shares are lower in after-market hours, settling within the middle of their one-month trading range amid a broader risk-off sentiment.

2026. jún. 26. 23:51 UTC

ETF Constituents

Vanguard Information Technology ETF shows modest gains after-market, driven by NVIDIA and Apple, despite mixed broader market conditions and declines in global equity indices.

2026. jún. 26. 23:51 UTC

Macro News

The FTSE 100 Index is trading lower in after-market hours amid concerns over stagflation and rising long-term yields, according to UBS Asset Management.

2026. jún. 26. 23:51 UTC

Macro Event
Correlated Moves

Bitcoin is higher today, influenced by positive U.S. economic data. The Goods Trade Balance deficit and Wholesale Inventories report are contributing factors to the movement.

2026. jún. 26. 23:51 UTC

ETF Constituents

iShares MSCI South Korea ETF gains after market close, supported by SKM's performance. The asset remains below its 20-day moving average.

2026. jún. 26. 23:51 UTC

Cognizant Technology Solutions Corp shares are higher in after-market trading, recovering from a low earlier in the session, though still below the 20-day moving average.

2026. jún. 26. 23:51 UTC

Social Media
ETF Constituents

Health Care Select Sector SPDR Fund shows slight gains in after-market trading, buoyed by strong performance from top holdings and bullish sentiment toward healthcare equities.

2026. jún. 26. 23:46 UTC

Cisco Systems Inc. shares are higher in after-market trading, reflecting routine activity, though the stock remains below its 20-day moving average.

2026. jún. 26. 23:46 UTC

Correlated Moves

Mondelez International Inc shares are lower in after-market trading, reflecting broader declines in the consumer goods sector amid inflation concerns and risk-off sentiment.

2026. jún. 26. 23:46 UTC

Correlated Moves

Cadence Design Systems shares are lower in after-market trading, reflecting broader risk-off sentiment amid inflation concerns and Synopsys Inc's recent stock decline.

2026. jún. 26. 23:46 UTC

Expedia Group Inc. shares are roughly flat in after-market trading, reflecting routine performance within a broader context above its 20-day moving average.

2026. jún. 26. 23:46 UTC

ETF Constituents

SPDR S&P Regional Banking ETF declines slightly after-hours, reflecting mixed U.S. market performance amid ongoing inflation concerns and declines in major global indices.

Társak összehasonlítása

Árváltozás

Novartis AG Előrejelzés

Célár

By TipRanks

10.07% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 171.06 USD  10.07%

Magas 180 USD

Alacsony 160 USD

3 Wall Street elemző 12 hónapos célárain alapulva a(z)Novartis AG termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

3 ratings

2

Vétel

1

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
help-icon Live chat